Kimball Electronics (NASDAQ:KE) surpassed analyst expectations for revenue and adjusted earnings per share in Q4 FY2025, with revenue at $380.5 million and EPS at $0.34. Sales grew sequentially, but year-over-year results declined due to automotive and industrial weakness. The company’s cautious outlook for FY2026 includes a projected 2%-9% decrease in net sales to $1,350-$1,450 million and adjusted operating income of 4.0%-4.25% of net sales, emphasizing a shift toward medical manufacturing. Kimball Electronics operates globally in automotive, medical, and industrial sectors, focusing on medical device manufacturing and cost optimization. The company reported Q4 FY2025 results, highlighting challenges and opportunities in various segments. Looking ahead, investors may monitor new business wins in medical manufacturing, automotive segment stability, and cost management as the company transitions to medical device work.

Read more at Nasdaq: Kimball Electronics Beats in Fiscal Q4